drugset
drugset / Trial / NCT04251819

Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers

NCT04251819 ↗

Phase 2/3 Terminated 19 enrolled University of Alabama at Birmingham
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine if baclofen will enhance buprenorphine analgesia for acute pain in healthy volunteers.

Timeline

Start
2021-01-21
Primary completion
2024-06-15
Completion
2024-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Baclofen Small molecule 5 mg —
Subject Baclofen Small molecule 10 mg —

Indications

No indication recorded.